Resverlogix Gets PIPE'd
Resverlogix Corp. (TSX), a Calgary-based biotech company, has sold C$24.25 million of units to NGN Capital, in a PIPE transaction.
16 April 2009•3 mins read
Resverlogix Corp. (TSX), a Calgary-based biotech company, has sold C$24.25 million of units to NGN Capital, in a PIPE transaction.
